Afficher la couverture 'COMBINATION THERAPY FOR ALZHEIMER’S DISEASE: PERSPECTIVES OF THE EU/US CTAD TASK FORCE | Gauthier, S.' en grand format
/5

0 avis

COMBINATION THERAPY FOR ALZHEIMER’S DISEASE: PERSPECTIVES OF THE EU/US CTAD TASK FORCE

Archive ouverte

Gauthier, S. | Alam, J. | Fillit, H. | Iwatsubo, T. | Liu-Seifert, H. | Sabbagh, M. | Salloway, S. | Sampaio, C. | Sims, J.R. | Sperling, B. | Sperling, R. | Welsh-Bohmer, K.A. | Touchon, J. | Vellas, B. | Aisen, P.

Edité par CCSD ; SERDI éd -

International audience. Combination therapy is expected to play an important role for the treatment of Alzheimer’s disease (AD). In October 2018, the European Union-North American Clinical Trials in Alzheimer’s Disease Task Force (EU/US CTAD Task Force) met to discuss scientific, regulatory, and logistical challenges to the development of combination therapy for AD and current efforts to address these challenges. Task Force members unanimously agreed that successful treatment of AD will likely require combination therapy approaches that target multiple mechanisms and pathways. They further agreed on the need for global collaboration and sharing of data and resources to accelerate development of such approaches.

Consulter en ligne

Suggestions

Du même auteur

Blood Biomarkers from Research Use to Clinical Practice. Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force

Archive ouverte | Angioni, D. | CCSD

International audience. Timely and accurate diagnosis of Alzheimer's disease (AD) in clinical practice remains challenging. PET and CSF biomarkers are the most widely used biomarkers to aid diagnosis in clinical res...

Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force

Archive ouverte | Angioni, D. | CCSD

International audience

Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force.

Archive ouverte | Aisen, P. | CCSD

International audience. The EU/US/CTAD Task Force, an international collaboration of AD investigators from industry and academia, met in Barcelona, Spain, on November 4th, 2015, to explore existing and planned patie...

Chargement des enrichissements...